General Information |
| Organization Type - Primary: |
Private Sector |
| Organization Type - Secondary: |
Company |
| Is your organization legally registered in your country: |
Yes |
| Organization Reach: |
International |
| Organization Description: |
| Leading producer of anti-TB drugs with a stong focus of research of new and novel treatments. |
| |
| Total number of staff in your organization: |
100 + |
| Number of full-time staff who are directly involved with TB: |
1 - 5 |
| Number of part-time staff who are directly involved with TB: |
0 |
| Number of volunteers who are directly involved with TB: |
0 |
| |
| What is your organization's annual budget (USD) dedicated to TB? |
Unable to disclose amount |
| How did you hear about the Stop TB Partnership: |
Involvement in TB control provision |
| Why do you wish join the Stop TB Partnership: |
Involvement in Stop TB Working Groups |
| |
| Are you a member of a Stop TB national partnership: |
No |
| Are you in contact with your national TB programme: |
Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: |
We are laeading suppliers to Anti TB medicines to the programme and ensure that the medicines are available to the patients at best possible prices and ensure that the supply is continuous and there is no stock out situations.
We actively participate in various symposiums organized by the programme. |
| |
Geographical Reach |
| Which country is your headquarters located in: |
India |
| Which WHO region is the main focus of your work: |
South East Asian |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan Algeria Australia Azerbaijan Bangladesh Botswana Brazil Cambodia Canada Chad China Colombia Egypt Fiji Germany India Indonesia Iran (Islamic Republic of) Iraq Kenya Malaysia Mexico Myanmar Nepal New Zealand Nigeria Saudi Arabia Singapore South Africa Sri Lanka Turkey United Kingdom of Great Britain and Northern Ireland Zambia |